Toggle navigation
Home
Search
Services
Blog
Contact
About
Temozolomide Resistance in CNS Tumors
Friedman, Henry S.
Duke University, Durham, NC, United States
Search 102 grants from Henry Friedman
Search grants from Duke University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Targeting Sirtuin-1 to enhance Foxp3+ regulatory T-cell function
T cell dysregulation in Systemic Lupus Erythematosus-Accelerated Atherosclerosis
Human Gene Knockdowns that May Extend Lifespan
Cell Polarity Signaling in C. elegans Embryos
Statistical Methods for Randomly Repeated Measures
Recently added grants:
Identifying Novel Therapeutics for High Risk Medulloblastoma Patients
Implication of Galectin-3 to regulate Graft vs. Host Disease (GvHD) and Graft vs. Tumor (GvT) Responses
Identification of genetic and environmental suppressors of mitochondrial dysfunction
Development and application of new tools to identify repeat expansions in human diseases
Role of Kdm5c dosage in mouse neural development
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21CA081651-02
Application #
6174372
Study Section
Special Emphasis Panel (ZRG1-ET-1 (04))
Program Officer
Wu, Roy S
Project Start
1999-04-01
Project End
2001-03-31
Budget Start
2000-04-01
Budget End
2001-03-31
Support Year
2
Fiscal Year
2000
Total Cost
$154,000
Indirect Cost
Institution
Name
Duke University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Related projects
NIH 2000
R21 CA
Temozolomide Resistance in CNS Tumors
Friedman, Henry S. / Duke University
$154,000
NIH 1999
R21 CA
Temozolomide Resistance in CNS Tumors
Friedman, Henry S. / Duke University
Comments
Be the first to comment on Henry Friedman's grant